Primary cardiac angiosarcoma: 53 months' survival after multidisciplinary therapy

Ann Thorac Surg. 1997 Apr;63(4):1160-1. doi: 10.1016/s0003-4975(96)01395-1.

Abstract

An 8-year-old girl underwent surgical excision of a tumor arising from the right atrium immediately after admission. Because histologic and immunohistochemical examination confirmed the diagnosis of angiosarcoma, adjunctive multidisciplinary therapy was administered for the following 2 years. She is leading a normal school life 53 months after the operation. Therapeutic strategy for this highly malignant cardiac tumor is discussed.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child
  • Combined Modality Therapy
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Doxorubicin / analogs & derivatives
  • Female
  • Heart Neoplasms / drug therapy
  • Heart Neoplasms / pathology
  • Heart Neoplasms / surgery
  • Heart Neoplasms / therapy*
  • Hemangiosarcoma / drug therapy
  • Hemangiosarcoma / pathology
  • Hemangiosarcoma / surgery
  • Hemangiosarcoma / therapy*
  • Humans
  • Ifosfamide / administration & dosage
  • Survivors
  • Time Factors

Substances

  • Dacarbazine
  • Doxorubicin
  • pirarubicin
  • Ifosfamide